Back to Authors

Mahgoub, Bayan

https://orcid.org/0000-0001-5677-8784

Mayo Clinic

University of Virginia

Citations 2

Inducible nitric oxide synthase (iNOS) mediated inhibition of T cell receptor (TCR) signaling is a mechanism for eosinophil dependent amelioration of alloimmunity in lung grafts
Onyema, Oscar Okwudiri , Guo, Yizhan, Mahgoub, Bayan , Manafi, Amir , Criswell, Stacey J , Kreisel, Daniel , Krupnick, Alexander S. , Lannigan, Joanne , Jacobsen, Elizabeth A. , Gelman, Andrew E

The Journal of Immunology | January 1, 2023 | Volume: 202 | Issue: 1_Supplement | Pages: 69.9-69.9

10.4049/jimmunol.202.supp.69.9 Get It

Abstract Eosinophils play a surprising role in downregulating lung graft-specific alloimmunity, even without immunosuppression. We demonstrate here, a mechanism used by eosinophils to downregulate alloimmune responses. To study the mechanism of eosinophil dependent downregulation of alloimmune responses, we used a model of diphtheria toxin (DT) dependent ablation of eosinophils in iPHIL, a mouse model expressing DT receptor on the eosinophil-peroxidase gene locus. Fully MHC-mismatched Balb/c (H2Kd) lungs were engrafted to iPHIL (H2Kb) recipients without immunosuppression. We modeled alloreactivity in vitro, with mixed leukocyte cultures, comprising Th1-polarized eosinophils as modulators of T cells from C57BL/6J or Nur77-GFP mice stimulated by either allogeneic dendritic cells or anti-CD3/CD28 agonistic antibodies. Ablation of eosinophils in non-immunosuppressed lung graft recipients leads to enhanced T cell activation and graft rejection. Similarly, in vitro, we observed a dose and contact dependent downregulation of T cell activation by eosinophils. While contact between eosinophils and T cells is mediated through the upregulation of PD-L1 on both wild-type and iNOS−/− eosinophils after TH-1 polarization, the inhibition of T cell activation is iNOS dependent and is directly linked to the iNOS dependent inhibition of the TCR signaling early gene, Nr4a1, monitored in Nur77-GFP mice. Thus, following contact with T cells, iNOS-expressing eosinophils downregulate lung graft alloimmunity through a direct effect on TCR engagement early genes, leading to the inhibition of T cell activation. This provides an explanation for the surprising observation of lung-graft specific alloimmune downregulation by eosinophils.
Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction
Onyema, Oscar Okwudiri , Guo, Yizhan , Mahgoub, Bayan , Wang, Qing , Manafi, Amir , Mei, Zhongcheng , Banerjee, Anirban , Li, Dongge , Stoler, Mark H. , Zaidi, Melissa T. , Schrum, Adam G. , Kreisel, Daniel , Jacobsen, Elizabeth A. , Krupnick, Alexander S. , Schrum, Adam G , Jacobsen, Elizabeth A , Gelman, Andrew E

JCI Insight | June 5, 2019 | Volume: 4 | Issue: 11 | Pages: No page available

10.1172/jci.insight.128241 Get It

Despite the accepted notion that granulocytes play a universally destructive role in organ and tissue grafts, it has been recently described that eosinophils can facilitate immunosuppression-mediated acceptance of murine lung allografts. The mechanism of eosinophil-mediated tolerance, or their role in regulating alloimmune responses in the absence of immunosuppression, remains unknown. Using lung transplants in a fully MHC-mismatched BALB/c (H2 d ) to C57BL/6 (H2 b ) strain combination, we demonstrate that eosinophils downregulate T cell–mediated immune responses and play a tolerogenic role even in the absence of immunosuppression. We further show that such downregulation depends on PD-L1/PD-1–mediated synapse formation between eosinophils and T cells. We also demonstrate that eosinophils suppress T lymphocyte responses through the inhibition of T cell receptor/CD3 (TCR/CD3) subunit association and signal transduction in an inducible NOS–dependent manner. Increasing local eosinophil concentration, through administration of intratracheal eotaxin and IL-5, can ameliorate alloimmune responses in the lung allograft. Thus, our data indicate that eosinophil mobilization may be utilized as a novel means of lung allograft–specific immunosuppression.